- Home
- MNKD vs DAC Comparison
MNKD vs DAC Comparison
Compare MNKD & DAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- DAC
- Stock Information
- Founded
- MNKD 1991
- DAC 1972
- Country
- MNKD United States
- DAC Greece
- Employees
- MNKD N/A
- DAC N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- DAC Marine Transportation
- Sector
- MNKD Health Care
- DAC Consumer Discretionary
- Exchange
- MNKD Nasdaq
- DAC Nasdaq
- Market Cap
- MNKD 1.8B
- DAC 1.6B
- IPO Year
- MNKD 2004
- DAC 2006
- Fundamental
- Price
- MNKD $6.80
- DAC $85.72
- Analyst Decision
- MNKD Strong Buy
- DAC Strong Buy
- Analyst Count
- MNKD 5
- DAC 1
- Target Price
- MNKD $8.40
- DAC $105.00
- AVG Volume (30 Days)
- MNKD 2.9M
- DAC 112.6K
- Earning Date
- MNKD 11-07-2024
- DAC 11-12-2024
- Dividend Yield
- MNKD N/A
- DAC 3.73%
- EPS Growth
- MNKD N/A
- DAC 0.27
- EPS
- MNKD 0.08
- DAC 28.90
- Revenue
- MNKD $267,200,000.00
- DAC $1,005,246,000.00
- Revenue This Year
- MNKD $46.83
- DAC $4.87
- Revenue Next Year
- MNKD $14.40
- DAC N/A
- P/E Ratio
- MNKD $85.77
- DAC $2.97
- Revenue Growth
- MNKD 51.35
- DAC 2.92
- 52 Week Low
- MNKD $3.17
- DAC $66.45
- 52 Week High
- MNKD $7.63
- DAC $98.25
- Technical
- Relative Strength Index (RSI)
- MNKD 47.15
- DAC 59.18
- Support Level
- MNKD $6.61
- DAC $80.25
- Resistance Level
- MNKD $7.44
- DAC $89.40
- Average True Range (ATR)
- MNKD 0.35
- DAC 2.15
- MACD
- MNKD -0.05
- DAC 0.48
- Stochastic Oscillator
- MNKD 18.63
- DAC 62.30
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About DAC Danaos Corporation
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.